131 related articles for article (PubMed ID: 12031996)
1. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass.
Kimmel SE; Sekeres M; Berlin JA; Ellison N
Anesth Analg; 2002 Jun; 94(6):1402-8, table of contents. PubMed ID: 12031996
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass.
Kimmel SE; Sekeres MA; Berlin JA; Ellison N; DiSesa VJ; Strom BL
J Am Coll Cardiol; 1998 Dec; 32(7):1916-22. PubMed ID: 9857872
[TBL] [Abstract][Full Text] [Related]
3. Adverse events after protamine administration following cardiopulmonary bypass in infants and children.
Seifert HA; Jobes DR; Ten Have T; Kimmel SE; Montenegro LM; Steven JM; Nicolson SC; Strom BL
Anesth Analg; 2003 Aug; 97(2):383-389. PubMed ID: 12873922
[TBL] [Abstract][Full Text] [Related]
4. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
[TBL] [Abstract][Full Text] [Related]
5. Case 3--2000. Improper administration of protamine during cardiopulmonary bypass.
Karaaslan D; Akpek EA; Sekerci S; Arslan G; Stammers A
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):327-9. PubMed ID: 10890491
[No Abstract] [Full Text] [Related]
6. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
7. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
Comunale ME; Maslow A; Robertson LK; Haering JM; Mashikian JS; Lowenstein E
J Cardiothorac Vasc Anesth; 2003 Jun; 17(3):309-13. PubMed ID: 12827577
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery.
Welsby IJ; Newman MF; Phillips-Bute B; Messier RH; Kakkis ED; Stafford-Smith M
Anesthesiology; 2005 Feb; 102(2):308-14. PubMed ID: 15681944
[TBL] [Abstract][Full Text] [Related]
9. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
[TBL] [Abstract][Full Text] [Related]
10. Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.
Kimmel SE; Sekeres MA; Berlin JA; Goldberg LR; Strom BL
J Clin Epidemiol; 1998 Jan; 51(1):1-10. PubMed ID: 9467629
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
[TBL] [Abstract][Full Text] [Related]
12. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
[TBL] [Abstract][Full Text] [Related]
13. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
[TBL] [Abstract][Full Text] [Related]
15. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
16. Life threatening cardiopulmonary failure in an infant following protamine reversal of heparin after cardiopulmonary bypass.
Boigner H; Lechner E; Brock H; Golej J; Trittenwein G
Paediatr Anaesth; 2001 Nov; 11(6):729-32. PubMed ID: 11696152
[TBL] [Abstract][Full Text] [Related]
17. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
18. [About severe shock after protamine infusion in a neonate undergoing cardiopulmonary bypass].
Ponvert C
Ann Fr Anesth Reanim; 2014 Jan; 33(1):48-9. PubMed ID: 24378040
[No Abstract] [Full Text] [Related]
19. Probable reversal of protamine reactions by heparin administration.
Lock R; Hessel EA
J Cardiothorac Anesth; 1990 Oct; 4(5):604-8. PubMed ID: 2132139
[No Abstract] [Full Text] [Related]
20. Can the Minimum Protamine Dose to Neutralize Heparin at the Completion of Cardiopulmonary Bypass be Significantly Lower than the Conventional Practice?
Lee MH; Riley W; Shann KG
J Extra Corpor Technol; 2021 Sep; 53(3):170-176. PubMed ID: 34658407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
